Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics has informed the stock exchanges that its Board of Directors will meet on November 14, 2025 (per BSE headline; the letter body contains a date typo referencing August 14, 2025). The main agenda is to consider and approve the unaadited financial results for the quarter and half year ended September 30, 2025 (Q2 FY26). The meeting may also take up any other matter with the Chairperson's permission. As per insider trading rules, the trading window for the stock remains closed until 48 hours after the results are declared.
This is a routine pre-results intimation and carries no immediate impact on shareholders. Investors should watch for the actual Q2/H1 FY26 numbers, as they could move the stock depending on whether revenue and profit grow, stay flat, or disappoint versus expectations.